Global Graves Disease Market Size, Status and Forecast 2020-2026
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Market Analysis by Type
- 1.3.1 Global Graves Disease Market Size Growth Rate by Type: 2020 VS 2026
- 1.3.2 Anti-Thyroid Drugs
- 1.3.3 Lodine &Lodides
- 1.3.4 Radioactive Lodine
- 1.3.5 Lonic Inhibitors
- 1.4 Market by Application
- 1.4.1 Global Graves Disease Market Share by Application: 2020 VS 2026
- 1.4.2 Hospital Pharmacy
- 1.4.3 Online Pharmacy
- 1.4.4 Retail Pharmacy
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Graves Disease Market Perspective (2015-2026)
- 2.2 Graves Disease Growth Trends by Regions
- 2.2.1 Graves Disease Market Size by Regions: 2015 VS 2020 VS 2026
- 2.2.2 Graves Disease Historic Market Share by Regions (2015-2020)
- 2.2.3 Graves Disease Forecasted Market Size by Regions (2021-2026)
- 2.3 Graves Disease Industry Dynamic
- 2.3.1 Graves Disease Market Trends
- 2.3.2 Graves Disease Market Drivers
- 2.3.3 Graves Disease Market Challenges
- 2.3.4 Graves Disease Market Restraints
3 Competition Landscape by Key Players
- 3.1 Global Top Graves Disease Players by Market Size
- 3.1.1 Global Top Graves Disease Players by Revenue (2015-2020)
- 3.1.2 Global Graves Disease Revenue Market Share by Players (2015-2020)
- 3.2 Global Graves Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Players Covered: Ranking by Graves Disease Revenue
- 3.4 Global Graves Disease Market Concentration Ratio
- 3.4.1 Global Graves Disease Market Concentration Ratio (CR5 and HHI)
- 3.4.2 Global Top 10 and Top 5 Companies by Graves Disease Revenue in 2019
- 3.5 Key Players Graves Disease Area Served
- 3.6 Key Players Graves Disease Product Solution and Service
- 3.7 Date of Enter into Graves Disease Market
- 3.8 Mergers & Acquisitions, Expansion Plans
4 Graves Disease Breakdown Data by Type
- 4.1 Global Graves Disease Historic Market Size by Type (2015-2020)
- 4.2 Global Graves Disease Forecasted Market Size by Type (2021-2026)
5 Graves Disease Breakdown Data by Application
- 5.1 Global Graves Disease Historic Market Size by Application (2015-2020)
- 5.2 Global Graves Disease Forecasted Market Size by Application (2021-2026)
6 North America
- 6.1 North America Graves Disease Market Size (2015-2026)
- 6.2 North America Graves Disease Market Size by Type (2015-2020)
- 6.3 North America Graves Disease Market Size by Application (2015-2020)
- 6.4 North America Graves Disease Market Size by Country (2015-2020)
- 6.4.1 United States
- 6.4.2 Canada
7 Europe
- 7.1 Europe Graves Disease Market Size (2015-2026)
- 7.2 Europe Graves Disease Market Size by Type (2015-2020)
- 7.3 Europe Graves Disease Market Size by Application (2015-2020)
- 7.4 Europe Graves Disease Market Size by Country (2015-2020)
- 7.4.1 Germany
- 7.4.2 France
- 7.4.3 U.K.
- 7.4.4 Italy
- 7.4.5 Russia
- 7.4.6 Nordic
8 Asia-Pacific
- 8.1 Asia-Pacific Graves Disease Market Size (2015-2026)
- 8.2 Asia-Pacific Graves Disease Market Size by Type (2015-2020)
- 8.3 Asia-Pacific Graves Disease Market Size by Application (2015-2020)
- 8.4 Asia-Pacific Graves Disease Market Size by Region (2015-2020)
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 South Korea
- 8.4.4 Southeast Asia
- 8.4.5 India
- 8.4.6 Australia
9 Latin America
- 9.1 Latin America Graves Disease Market Size (2015-2026)
- 9.2 Latin America Graves Disease Market Size by Type (2015-2020)
- 9.3 Latin America Graves Disease Market Size by Application (2015-2020)
- 9.4 Latin America Graves Disease Market Size by Country (2015-2020)
- 9.4.1 Mexico
- 9.4.2 Brazil
10 Middle East & Africa
- 10.1 Middle East & Africa Graves Disease Market Size (2015-2026)
- 10.2 Middle East & Africa Graves Disease Market Size by Type (2015-2020)
- 10.3 Middle East & Africa Graves Disease Market Size by Application (2015-2020)
- 10.4 Middle East & Africa Graves Disease Market Size by Country (2015-2020)
- 10.4.1 Turkey
- 10.4.2 Saudi Arabia
- 10.4.3 UAE
11Key Players Profiles
- 11.1 Abbott Laboratories
- 11.1.1 Abbott Laboratories Company Details
- 11.1.2 Abbott Laboratories Business Overview
- 11.1.3 Abbott Laboratories Graves Disease Introduction
- 11.1.4 Abbott Laboratories Revenue in Graves Disease Business (2015-2020))
- 11.1.5 Abbott Laboratories Recent Development
- 11.2 GlaxoSmithKline plc
- 11.2.1 GlaxoSmithKline plc Company Details
- 11.2.2 GlaxoSmithKline plc Business Overview
- 11.2.3 GlaxoSmithKline plc Graves Disease Introduction
- 11.2.4 GlaxoSmithKline plc Revenue in Graves Disease Business (2015-2020)
- 11.2.5 GlaxoSmithKline plc Recent Development
- 11.3 Merck & Co
- 11.3.1 Merck & Co Company Details
- 11.3.2 Merck & Co Business Overview
- 11.3.3 Merck & Co Graves Disease Introduction
- 11.3.4 Merck & Co Revenue in Graves Disease Business (2015-2020)
- 11.3.5 Merck & Co Recent Development
- 11.4 Pfizer, Inc
- 11.4.1 Pfizer, Inc Company Details
- 11.4.2 Pfizer, Inc Business Overview
- 11.4.3 Pfizer, Inc Graves Disease Introduction
- 11.4.4 Pfizer, Inc Revenue in Graves Disease Business (2015-2020)
- 11.4.5 Pfizer, Inc Recent Development
- 11.5 RLC LABS
- 11.5.1 RLC LABS Company Details
- 11.5.2 RLC LABS Business Overview
- 11.5.3 RLC LABS Graves Disease Introduction
- 11.5.4 RLC LABS Revenue in Graves Disease Business (2015-2020)
- 11.5.5 RLC LABS Recent Development
- 11.6 AbbVie, Inc
- 11.6.1 AbbVie, Inc Company Details
- 11.6.2 AbbVie, Inc Business Overview
- 11.6.3 AbbVie, Inc Graves Disease Introduction
- 11.6.4 AbbVie, Inc Revenue in Graves Disease Business (2015-2020)
- 11.6.5 AbbVie, Inc Recent Development
- 11.7 Mylan N.V
- 11.7.1 Mylan N.V Company Details
- 11.7.2 Mylan N.V Business Overview
- 11.7.3 Mylan N.V Graves Disease Introduction
- 11.7.4 Mylan N.V Revenue in Graves Disease Business (2015-2020)
- 11.7.5 Mylan N.V Recent Development
- 11.8 Allergan, plc
- 11.8.1 Allergan, plc Company Details
- 11.8.2 Allergan, plc Business Overview
- 11.8.3 Allergan, plc Graves Disease Introduction
- 11.8.4 Allergan, plc Revenue in Graves Disease Business (2015-2020)
- 11.8.5 Allergan, plc Recent Development
12Analyst's Viewpoints/Conclusions
13Appendix
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.2 Data Source
- 13.2 Disclaimer
Graves Disease market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Graves Disease market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Market segment by Type, the product can be split into
Anti-Thyroid Drugs
Lodine &Lodides
Radioactive Lodine
Lonic Inhibitors
Market segment by Application, split into
Hospital Pharmacy
Online Pharmacy
Retail Pharmacy
Based on regional and country-level analysis, the Graves Disease market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
In the competitive analysis section of the report, leading as well as prominent players of the global Graves Disease market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
Abbott Laboratories
GlaxoSmithKline plc
Merck & Co
Pfizer, Inc
RLC LABS
AbbVie, Inc
Mylan N.V